No Pharma Money
News & Reports
News April 13, 2020

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

With promising news on the horizon, we cannot stress this enough – stay home and save lives!

1. Taxpayers deserve a good deal

  • In the race to find COVID-19 vaccines and treatments, taxpayers are investing in research to get the job done. Drug corporations shouldn’t be allowed to set prices on products taxpayers helped to research and develop — they must partner with the US government to set fair and affordable prices for everyone. — (Inside Health Policy)

2. Patients make it happen ?

  • After patients penned a letter calling on insulin manufacturers to lower the price of insulin during the COVID-19 crisis, Eli Lilly announced they would offer a program that allows people with diabetes to purchase their insulin products for $35 a month. It’s a win for patients, but we still need action to *lower list prices for ALL.* — (CNBC)

3. Drug Pricing Reform NOW

  • From Maine to Nebraska, Americans are calling on Congress to take action and lower the cost of prescription drugs by passing the Prescription Drug Pricing Reform Act. — (Bangor Daily News) and (Lincoln Journal Star)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.